A Phase 1/2 Trial Evaluating the Safety and Immunogenicity of an mRNA-based Seasonal Influenza Vaccine Candidate Encoding Hemagglutinin and Neuraminidase.
- DOI
- 10.1007/s40121-026-01463-9
- Published
- 2026 Oct 15
- Container
- Infectious diseases and therapy
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1007/s40121-026-01463-9,
title = {A Phase 1/2 Trial Evaluating the Safety and Immunogenicity of an mRNA-based Seasonal Influenza Vaccine Candidate Encoding Hemagglutinin and Neuraminidase.},
author = {De Coster I and Cardona JF and Ferguson M and Leroux-Roels I and Nell H and Berrè S and Schoonbroodt S and Lorin C and Ovbude LJ and Moldt B and FLU SV mRNA-002 study group},
year = {2026},
journal = {Infectious diseases and therapy},
doi = {10.1007/s40121-026-01463-9},
url = {https://doi.org/10.1007/s40121-026-01463-9}
}RIS
TY - JOUR TI - A Phase 1/2 Trial Evaluating the Safety and Immunogenicity of an mRNA-based Seasonal Influenza Vaccine Candidate Encoding Hemagglutinin and Neuraminidase. AU - De Coster I AU - Cardona JF AU - Ferguson M AU - Leroux-Roels I AU - Nell H AU - Berrè S AU - Schoonbroodt S AU - Lorin C AU - Ovbude LJ AU - Moldt B AU - FLU SV mRNA-002 study group PY - 2026 JO - Infectious diseases and therapy DO - 10.1007/s40121-026-01463-9 UR - https://doi.org/10.1007/s40121-026-01463-9 ER -
APA
I, D. C., JF, C., M, F., I, L., H, N., S, B., S, S., C, L., LJ, O., B, M., & group, F. S. M. S. (2026). A Phase 1/2 Trial Evaluating the Safety and Immunogenicity of an mRNA-based Seasonal Influenza Vaccine Candidate Encoding Hemagglutinin and Neuraminidase.. Infectious diseases and therapy. https://doi.org/10.1007/s40121-026-01463-9
Source records
- pubmed · retrieved 2026-11-10T10:37:55.672Z